Comparative statistics by cancer registry

Registry: Comparative statistics by cancer site

Table3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site

(Izmir, Turkey, 1995-1997 cases followed-up until 2003)

Click on cancer site (ICD-10 code) for comparison
SiteICD-10TotalAbsolute survival %Relative survival %ASRS% at 5-years
1-year3-year5-year1-year3-year5-yearall ages0-74 years
C18Colon37173.853.644.976.058.752.553.252.2
C19-20Rectum34482.955.944.185.060.150.451.652.0
C32Larynx47887.970.262.290.075.670.968.971.4
C50Breast132996.381.371.197.684.976.776.677.2
C53Cervix24689.768.258.890.770.562.357.663.5
C56Ovary23083.462.954.784.765.759.060.259.7
C67Urinary bladder56684.767.357.787.775.169.769.970.7
C81Hodgkin lymphoma8592.577.465.693.379.368.667.965.8
C82-85+C96Non-Hodgkin lymphoma34472.651.045.173.953.849.549.850.6
C90Multiple myeloma7965.843.028.567.346.232.331.631.1
C91Lymphoid leukaemia16178.155.548.279.257.651.452.650.1
C92-94Myeloid leukaemia14865.741.229.567.043.432.233.034.2


Graphs:


Other tables available for this registry:
- Table1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Izmir, Turkey, 1995-1997 cases followed-up until 2003)
- Table2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site (Izmir, Turkey, 1995-1997 cases followed-up until 2003)
- Table3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Izmir, Turkey, 1995-1997 cases followed-up until 2003)
- Table4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Izmir, Turkey, 1995-1997 cases followed-up until 2003)
- Table5b: Proportion (%) of cases and 5-year absolute survival by extent of disease and site (Izmir, Turkey, 1995-1997)




Registry chapter:


Consult the chapter in Cancer survival in developping countries (Volume II)